Tanus-Santos JE - Search Results

1

Tempol improves xanthine oxidoreductase-mediated vascular responses to nitrite in experimental renovascular hypertension.

Oliveira-Paula GH, Pinheiro LC, Guimaraes DA, Tella SO, Blanco AL, Angelis CD, Schechter AN, Tanus-Santos JE. Oliveira-Paula GH, et al. Redox Biol. 2016 Aug;8:398-406. doi: 10.1016/j.redox.2016.04.001. Epub 2016 Apr 5. Redox Biol. 2016. PMID: 27078869 Free PMC article.

2

Cell-free hemoglobin limits nitric oxide bioavailability in sickle-cell disease.

Reiter CD, Wang X, Tanus-Santos JE, Hogg N, Cannon RO 3rd, Schechter AN, Gladwin MT. Reiter CD, et al. Nat Med. 2002 Dec;8(12):1383-9. doi: 10.1038/nm1202-799. Epub 2002 Nov 11. Nat Med. 2002. PMID: 12426562

3

Uncontrolled hypertension, uncompensated type II diabetes, and smoking have different patterns of vascular dysfunction.

Yugar-Toledo JC, Tanus-Santos JE, Sabha M, Sousa MG, Cittadino M, Tácito LH, Moreno H Jr. Yugar-Toledo JC, et al. Chest. 2004 Mar;125(3):823-30. doi: 10.1378/chest.125.3.823. Chest. 2004. PMID: 15006938

4

Low-dose intravenous nitrite improves hemodynamics in a canine model of acute pulmonary thromboembolism.

Dias-Junior CA, Gladwin MT, Tanus-Santos JE. Dias-Junior CA, et al. Free Radic Biol Med. 2006 Dec 15;41(12):1764-70. doi: 10.1016/j.freeradbiomed.2006.08.022. Epub 2006 Sep 1. Free Radic Biol Med. 2006. PMID: 17157179

5

Lercanidipine reduces matrix metalloproteinase-2 activity and reverses vascular dysfunction in renovascular hypertensive rats.

Martinez ML, Castro MM, Rizzi E, Fernandes K, Demacq C, Bendhack LM, Gerlach RF, Tanus-Santos JE. Martinez ML, et al. Eur J Pharmacol. 2008 Sep 4;591(1-3):224-30. doi: 10.1016/j.ejphar.2008.06.096. Epub 2008 Jul 2. Eur J Pharmacol. 2008. PMID: 18634778

6

Sildenafil improves the beneficial haemodynamic effects of intravenous nitrite infusion during acute pulmonary embolism.

Dias-Junior CA, Montenegro MF, Florencio BC, Tanus-Santos JE. Dias-Junior CA, et al. Basic Clin Pharmacol Toxicol. 2008 Oct;103(4):374-9. doi: 10.1111/j.1742-7843.2008.00299.x. Basic Clin Pharmacol Toxicol. 2008. PMID: 18834358 Free article.

7

Antioxidant treatment reduces matrix metalloproteinase-2-induced vascular changes in renovascular hypertension.

Castro MM, Rizzi E, Rodrigues GJ, Ceron CS, Bendhack LM, Gerlach RF, Tanus-Santos JE. Castro MM, et al. Free Radic Biol Med. 2009 May 1;46(9):1298-307. doi: 10.1016/j.freeradbiomed.2009.02.011. Epub 2009 Feb 25. Free Radic Biol Med. 2009. PMID: 19248829 Free article.

8

Spironolactone and hydrochlorothiazide exert antioxidant effects and reduce vascular matrix metalloproteinase-2 activity and expression in a model of renovascular hypertension.

Ceron CS, Castro MM, Rizzi E, Montenegro MF, Fontana V, Salgado MC, Gerlach RF, Tanus-Santos JE. Ceron CS, et al. Br J Pharmacol. 2010 May;160(1):77-87. doi: 10.1111/j.1476-5381.2010.00678.x. Epub 2010 Mar 19. Br J Pharmacol. 2010. PMID: 20331602 Free PMC article.

9

Matrix metalloproteinase inhibition improves cardiac dysfunction and remodeling in 2-kidney, 1-clip hypertension.

Rizzi E, Castro MM, Prado CM, Silva CA, Fazan R Jr, Rossi MA, Tanus-Santos JE, Gerlach RF. Rizzi E, et al. J Card Fail. 2010 Jul;16(7):599-608. doi: 10.1016/j.cardfail.2010.02.005. Epub 2010 Mar 19. J Card Fail. 2010. PMID: 20610236

10

Quercetin restores plasma nitrite and nitroso species levels in renovascular hypertension.

Montenegro MF, Neto-Neves EM, Dias-Junior CA, Ceron CS, Castro MM, Gomes VA, Kanashiro A, Tanus-Santos JE. Montenegro MF, et al. Naunyn Schmiedebergs Arch Pharmacol. 2010 Oct;382(4):293-301. doi: 10.1007/s00210-010-0546-1. Epub 2010 Aug 8. Naunyn Schmiedebergs Arch Pharmacol. 2010. PMID: 20694791

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

418 results

Search Page

Filters